ABIVAX press release
Marc de Garidel is appointed Chief Executive Officer and interim Chairman of the Board of Directors of Abivax.
Marc de Garidel’s appointment highlights Abivax’s positioning as one of the leading companies in the field of inflammatory bowel disease
Corinna zur Bonsen-Thomas steps down as President, while remaining a member of the Board of Directors of Abivax
Prof. Hartmut J. Ehrlich, MD steps down as CEO